Gil Blum
Stock Analyst at Needham
(4.47)
# 1,062
Out of 4,376 analysts
687
Total ratings
40.6%
Success rate
10.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintained: Hold | n/a | $2.21 | - | 22 | Jun 4, 2026 | |
| CELC Celcuity | Reiterated: Buy | $157 | $92.47 | +69.78% | 32 | Jun 2, 2026 | |
| IMCR Immunocore Holdings | Maintained: Buy | $75 | $28.76 | +160.78% | 22 | Jun 1, 2026 | |
| RNAC Cartesian Therapeutics | Maintained: Buy | $42 → $40 | $6.55 | +510.69% | 35 | May 26, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $26 | $15.28 | +70.16% | 44 | May 15, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $19 | $7.24 | +162.43% | 7 | May 14, 2026 | |
| AUTL Autolus Therapeutics | Maintained: Buy | $10 | $1.66 | +502.41% | 50 | May 14, 2026 | |
| NKTX Nkarta | Rated: Buy | $11 | $2.77 | +297.11% | 22 | May 13, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Buy | $3 | $0.318 | +843.40% | 34 | May 12, 2026 | |
| ARTV Artiva Biotherapeutics | Reiterated: Buy | $18 → $41 | $7.68 | +433.85% | 14 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.92 | - | 49 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $7.34 | -4.63% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $16.66 | - | 55 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $3.80 | +110.53% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $13.05 | +237.16% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.21 | +230.58% | 35 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.89 | +103.74% | 47 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.02 | +488.24% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 | $56.95 | +43.99% | 40 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.80 | - | 28 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.80 | - | 25 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.19 | n/a | 15 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 400.00 → kr 371.00 | $179.40 | n/a | 16 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $29.13 | n/a | 14 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $78.48 | n/a | 10 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 5 | Apr 6, 2022 |
Fate Therapeutics
Jun 4, 2026
Maintained: Hold
Price Target: n/a
Current: $2.21
Upside: -
Celcuity
Jun 2, 2026
Reiterated: Buy
Price Target: $157
Current: $92.47
Upside: +69.78%
Immunocore Holdings
Jun 1, 2026
Maintained: Buy
Price Target: $75
Current: $28.76
Upside: +160.78%
Cartesian Therapeutics
May 26, 2026
Maintained: Buy
Price Target: $42 → $40
Current: $6.55
Upside: +510.69%
Nurix Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $26
Current: $15.28
Upside: +70.16%
Solid Biosciences
May 14, 2026
Reiterated: Buy
Price Target: $19
Current: $7.24
Upside: +162.43%
Autolus Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
Nkarta
May 13, 2026
Rated: Buy
Price Target: $11
Current: $2.77
Upside: +297.11%
Mereo BioPharma Group
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.318
Upside: +843.40%
Artiva Biotherapeutics
May 12, 2026
Reiterated: Buy
Price Target: $18 → $41
Current: $7.68
Upside: +433.85%
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $2.92
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $7
Current: $7.34
Upside: -4.63%
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $16.66
Upside: -
May 7, 2026
Rated: Buy
Price Target: $8
Current: $3.80
Upside: +110.53%
May 7, 2026
Reiterated: Buy
Price Target: $44
Current: $13.05
Upside: +237.16%
May 6, 2026
Maintained: Buy
Price Target: $4
Current: $1.21
Upside: +230.58%
May 6, 2026
Reiterated: Buy
Price Target: $12
Current: $5.89
Upside: +103.74%
May 6, 2026
Maintained: Buy
Price Target: $6
Current: $1.02
Upside: +488.24%
May 5, 2026
Maintained: Buy
Price Target: $82
Current: $56.95
Upside: +43.99%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $4.80
Upside: -
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $1.80
Upside: -
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $3.19
Upside: n/a
Feb 16, 2023
Reiterated: Buy
Price Target: kr 400.00 → kr 371.00
Current: $179.40
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $6
Current: $29.13
Upside: n/a
Aug 25, 2022
Rated: Hold
Price Target: n/a
Current: $78.48
Upside: n/a
Jun 3, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 6, 2022
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a